CJC-1295 vs Ipamorelin
CJC-1295 (no DAC) and Ipamorelin are the two peptides most often paired in growth-hormone-secretagogue research, and are sold both separately and as a combined blend. Here is how they differ as research compounds, and how their vendor prices compare per milligram.
CJC-1295 (no DAC) is a modified growth-hormone-releasing-hormone (GHRH) analog used as a secretagogue reference compound in laboratory research.
Ipamorelin is a selective growth-hormone-secretagogue / ghrelin-receptor-agonist pentapeptide used as a reference compound in secretagogue research.
Links to vendors are affiliate links — we may earn a commission at no extra cost to you. Prices and stock are set by each vendor and may change. Peptide Technologies no longer sells retail.
- Mechanism class: CJC-1295 is a GHRH analog; Ipamorelin is a ghrelin-receptor (GHS-R) agonist — two different secretagogue pathways.
- Peptide size: CJC-1295 is a longer modified GHRH chain; Ipamorelin is a short pentapeptide.
- Research context: the two are commonly studied together because they act on complementary pathways.
- Availability: both ship as lyophilized vials and as a combined CJC-1295 (no DAC) + Ipamorelin research blend.
CJC-1295 vs Ipamorelin — FAQ
For laboratory research use only. Not for human or veterinary use, diagnosis, treatment, or consumption.